Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of Cancer

Max Kullberg, Alexandra Francian, Ameneh Arabi, Troy Olsson, Kristine Mann, Holly A. Martinson

Pharmaceutical Frontiers 2019;1(1):e190007; DOI:10.20900/pf20190007

Published on 28 November 2019

This article belongs to the Virtual Special Issue "Controlled and Targeted Release of Natural Drugs"

Desolvation Conditions for Production of Sulfasalazine Based Albumin Nanoparticles: Physical Properties

Victor Olaitan, Cheng Shu Chaw

Pharmaceutical Frontiers 2019;1(1):e190006; DOI:10.20900/pf20190006

Published on 14 August 2019

Generation of a Small Library of Natural Products Designed to Cover Chemical Space Inexpensively

Steve O’Hagan, Douglas B. Kell

Pharmaceutical Frontiers 2019;1(1):e190005; DOI:10.20900/pf20190005

Published on 9 August 2019

This article belongs to the Virtual Special Issue "The Evolving Role of Natural Products in Drug Discovery"

The Cancer Cell Killing Effects of Gynura procumbens, Toleaf Are Associated with CD4⁺ T Lymphocyte Activation

Keita Takanashi, Katsuaki Dan, Takaaki Matsuoka, Kazuhito Torii

Pharmaceutical Frontiers 2019;1(1):e190004; DOI:10.20900/pf20190004

Published on 21 June 2019

This article belongs to the Virtual Special Issue "The Evolving Role of Natural Products in Drug Discovery"

Safety Implications of Low-Dose Amitriptyline in Neuropathic Pain

Luana Mifsud Buhagiar, Marilyn Casha, Anton Grech, Benjamin Micallef, John Joseph Borg, Anthony Serracino Inglott, Godfrey LaFerla

Pharmaceutical Frontiers 2019;1(1):e190003; DOI:10.20900/pf20190003

Published on 28 May 2019

LOEWE Workshop Particle Characterization in Medicine and Biology

Mukul Ashtikar, Karsten Mäder, Martin Klein, Katrin Wunderlich, Pierre-Yves Lozach, Fiona Gao, Stefan Mende, Claire Strasser, Tom Dennison, Marco Marenchino, Matthias G. Wacker

Pharmaceutical Frontiers 2019;1(1):e190002; DOI:10.20900/pf20190002

Published on 28 November 2018

LOEWE Workshop Particle Characterization in Medicine and Biology

Mukul Ashtikar, Karsten Mäder, Martin Klein, Katrin Wunderlich, Pierre-Yves Lozach, Fiona Gao, Stefan Mende, Claire Strasser, Tom Dennison, Marco Marenchino, Matthias G. Wacker

Pharmaceutical Frontiers 2019;1(1):e190002; DOI:10.20900/pf20190002

Published on 28 November 2018

New Journal Launch: Pharmaceutical Frontiers

Michio Kurosu

Pharmaceutical Frontiers 2019;1(1):e190001; DOI:10.20900/pf20190001

Published on 28 November 2018

The Cancer Cell Killing Effects of Gynura procumbens, Toleaf Are Associated with CD4⁺ T Lymphocyte Activation

Keita Takanashi, Katsuaki Dan, Takaaki Matsuoka, Kazuhito Torii

Pharmaceutical Frontiers 2019;1(1):e190004; DOI:10.20900/pf20190004

Published on 21 June 2019

This article belongs to the Virtual Special Issue "The Evolving Role of Natural Products in Drug Discovery"

Safety Implications of Low-Dose Amitriptyline in Neuropathic Pain

Luana Mifsud Buhagiar, Marilyn Casha, Anton Grech, Benjamin Micallef, John Joseph Borg, Anthony Serracino Inglott, Godfrey LaFerla

Pharmaceutical Frontiers 2019;1(1):e190003; DOI:10.20900/pf20190003

Published on 28 May 2019

Desolvation Conditions for Production of Sulfasalazine Based Albumin Nanoparticles: Physical Properties

Victor Olaitan, Cheng Shu Chaw

Pharmaceutical Frontiers 2019;1(1):e190006; DOI:10.20900/pf20190006

Published on 14 August 2019

Generation of a Small Library of Natural Products Designed to Cover Chemical Space Inexpensively

Steve O’Hagan, Douglas B. Kell

Pharmaceutical Frontiers 2019;1(1):e190005; DOI:10.20900/pf20190005

Published on 9 August 2019

This article belongs to the Virtual Special Issue "The Evolving Role of Natural Products in Drug Discovery"

Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of Cancer

Max Kullberg, Alexandra Francian, Ameneh Arabi, Troy Olsson, Kristine Mann, Holly A. Martinson

Pharmaceutical Frontiers 2019;1(1):e190007; DOI:10.20900/pf20190007

Published on 28 November 2019

This article belongs to the Virtual Special Issue "Controlled and Targeted Release of Natural Drugs"

Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of Cancer

Max Kullberg, Alexandra Francian, Ameneh Arabi, Troy Olsson, Kristine Mann, Holly A. Martinson

Pharmaceutical Frontiers 2019;1(1):e190007; DOI:10.20900/pf20190007

Published on 28 November 2019

This article belongs to the Virtual Special Issue "Controlled and Targeted Release of Natural Drugs"

Generation of a Small Library of Natural Products Designed to Cover Chemical Space Inexpensively

Steve O’Hagan, Douglas B. Kell

Pharmaceutical Frontiers 2019;1(1):e190005; DOI:10.20900/pf20190005

Published on 9 August 2019

This article belongs to the Virtual Special Issue "The Evolving Role of Natural Products in Drug Discovery"

The Cancer Cell Killing Effects of Gynura procumbens, Toleaf Are Associated with CD4⁺ T Lymphocyte Activation

Keita Takanashi, Katsuaki Dan, Takaaki Matsuoka, Kazuhito Torii

Pharmaceutical Frontiers 2019;1(1):e190004; DOI:10.20900/pf20190004

Published on 21 June 2019

This article belongs to the Virtual Special Issue "The Evolving Role of Natural Products in Drug Discovery"